Medical Journals

Amyotrophic Lateral Sclerosis: All Roads Lead to Rome.

Authors:
  • Gonzalez de Aguilar Jose-Luis
  • Echaniz-Laguna Andoni
  • Fergani Anissa
  • René Frédérique
  • Meininger Vincent
  • Loeffler Jean-Philippe
  • Dupuis Luc

From: Inserm, U692, Laboratoire de Signalisations Moléculaires et Neurodégénérescence, Université Louis Pasteur, Faculté de Médecine, UMRS692, Strasbourg, France.

Journal of neurochemistry

  • Publish Date: Jun 2007
  • ISSN: 0022-3042
  • Volume: 101
  • Issue: 5
  • Pages: 1153-60
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gonzalez de Aguilar Jose-Luis, Echaniz-Laguna Andoni, Fergani Anissa, et al. Amyotrophic Lateral Sclerosis: All Roads Lead to Rome.. J. Neurochem. Jun 2007;101:1153-60

Abstract

Amyotrophic lateral sclerosis (ALS) is the most frequent adult-onset motor neuron disease characterized by degeneration of upper and lower motor neurons, generalized weakness and muscle atrophy. Most cases of ALS appear sporadically but some forms of the disease result from mutations in the gene encoding the antioxidant enzyme Cu/Zn superoxide dismutase (SOD1). Several other mutated genes have also been found to predispose to ALS including, among others, one that encodes the regulator of axonal retrograde transport dynactin. As all roads lead to the proverbial Rome, we discuss here how distinct molecular pathways may converge to the same final result that is motor neuron death. We critically review the basic research on SOD1-linked ALS to propose a pioneering model of a ‘systemic’ form of the disease, causally involving multiple cell types, either neuronal or non-neuronal. Contrasting this, we also postulate that other neuron-specific defects, as those triggered by dynactin dysfunction, may account for a primary motor neuron disease that would represent ‘pure’ neuronal forms of ALS. Identifying different disease subtypes is an unavoidable step toward the understanding of the physiopathology of ALS and will hopefully help to design specific treatments for each subset of patients.

Mesh Headings (Keywords): Amyotrophic Lateral Sclerosis, Animals, Disease Models, Animal, Humans, Microtubule-Associated Proteins, Models, Biological, Motor Neurons, Mutation, Superoxide Dismutase


Check for Full Text / PubMed Unique Identifier (PMID): 17250677


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.